Search research articles
Contact Us
Filters
Showing results (211-220 of 227) with videos related to
Page
of 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors
Joann P Palma, Yi-Chun Wang, Luis E Rodriguez, et al.
Molecular Cancer Therapeutics
|
March 4, 2015
Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody
Edward B Reilly, Andrew C Phillips, Fritz G Buchanan, et al.
Cancer Research
|
May 17, 2018
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates
James W Purcell, Sonia G Tanlimco, Jonathan Hickson, et al.
Journal of Virus Eradication
|
March 24, 2018
Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy
P Zangari, P Palma, N Cotugno, et al.
Journal of Virus Eradication
|
February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children
P Palma, C Foster, P Rojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2011
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor
Xuesong Liu, Yan Shi, David X Maag, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2012
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases
Michael L Curtin, H Robin Heyman, Robin R Frey, et al.
The Journal of Antimicrobial Chemotherapy
|
July 23, 2013
Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study
Gloria M González, Rogelio de J Treviño-Rangel, José P Palma-Nicolás, et al.
Anticancer Research
|
November 28, 2008
The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo
Joann P Palma, Luis E Rodriguez, Velitchka D Bontcheva-Diaz, et al.
Molecular Genetics and Metabolism
|
February 4, 2018
Prenatal treatment of ornithine transcarbamylase deficiency
Yael Wilnai, Yair J Blumenfeld, Kristina Cusmano, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 227) with videos related to
Sort By:
Page
of 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors
Joann P Palma, Yi-Chun Wang, Luis E Rodriguez, et al.
Molecular Cancer Therapeutics
|
March 4, 2015
Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody
Edward B Reilly, Andrew C Phillips, Fritz G Buchanan, et al.
Cancer Research
|
May 17, 2018
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates
James W Purcell, Sonia G Tanlimco, Jonathan Hickson, et al.
Journal of Virus Eradication
|
March 24, 2018
Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy
P Zangari, P Palma, N Cotugno, et al.
Journal of Virus Eradication
|
February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children
P Palma, C Foster, P Rojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2011
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor
Xuesong Liu, Yan Shi, David X Maag, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2012
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases
Michael L Curtin, H Robin Heyman, Robin R Frey, et al.
The Journal of Antimicrobial Chemotherapy
|
July 23, 2013
Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study
Gloria M González, Rogelio de J Treviño-Rangel, José P Palma-Nicolás, et al.
Anticancer Research
|
November 28, 2008
The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo
Joann P Palma, Luis E Rodriguez, Velitchka D Bontcheva-Diaz, et al.
Molecular Genetics and Metabolism
|
February 4, 2018
Prenatal treatment of ornithine transcarbamylase deficiency
Yael Wilnai, Yair J Blumenfeld, Kristina Cusmano, et al.
Page
of 23